Fifth Third Bancorp
IOVA icon

Fifth Third Bancorp’s Iovance Biotherapeutics IOVA Stock Holding History

Fifth Third Bancorp’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.4K Buy
15,000
+3,770
+34% +$14.3K ﹤0.01% 3153
2026
Q1 		$39.4K Buy
+11,230
New +$35.9K ﹤0.01% 3279
2024
Q3 		– Sell
-62
Closed -$497 – 2585
2024
Q2 		$497 Hold
62
– – ﹤0.01% 2384
2024
Q1 		$919 Buy
+62
New +$722 ﹤0.01% 2280
2022
Q2 		– Sell
-150
Closed -$2K – 2721
2022
Q1 		$2K Hold
150
– – ﹤0.01% 2530
2021
Q4 		$3K Buy
+150
New +$3.3K ﹤0.01% 2487

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Fifth Third Bancorp's IOVA Position: Q2 2026 in Review

Fifth Third Bancorp increased its Iovance Biotherapeutics (IOVA) stake by 34% in Q2 2026, buying an estimated $14.3K and bringing the position to 15,000 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3153.

Fifth Third Bancorp first reported a position in IOVA in Q4 2021 and has held it in 6 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Fifth Third Bancorp held 15,000 shares of Iovance Biotherapeutics worth $62.4K as of Q2 2026.
  • Fifth Third Bancorp bought 3,770 Iovance Biotherapeutics shares in Q2 2026, an estimated $14.3K.
  • Iovance Biotherapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3153 holding.
  • Fifth Third Bancorp first reported a position in Iovance Biotherapeutics in Q4 2021 and has held it in 6 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.